News

Rivian Adjusts Production Forecast, Shares See Decline

Rivian Adjusts Production Forecast, Shares See Decline

Rivian Reports Decline in Vehicle Production Numbers

Shares of Rivian Automotive, Inc. (NASDAQ: RIVN) dropped by 3.2%, settling at $10.44, following the announcement of its third-quarter production and delivery results alongside a reduction in its 2024 production forecast. The electric vehicle manufacturer produced 13,157 vehicles in its facility, a reduction from 16,304 units in the same quarter the previous year.

In terms of deliveries, Rivian managed to deliver only 10,018 vehicles. This figure, too, fell short of the previous year's total of 15,564 units. Such outcomes not only disappointed investors but also missed the analyst expectations from FactSet, which had forecasted deliveries of 13,000 vehicles for the quarter.

Challenges in Production Due to Component Shortages

The company is currently navigating through production challenges largely attributed to a shortage of components for its R1 and RCV models. This supply issue, which took root in the third quarter, has escalated recently, prompting Rivian to revise its annual vehicle production estimate to a range of 47,000 to 49,000 units. This marks a significant decrease from the earlier forecast of 57,000 units. However, Rivian has maintained its annual delivery target between 50,500 and 52,000 vehicles.

Strategic Joint Venture with Volkswagen

Earlier in the year, Rivian entered into a noteworthy $5 billion joint venture with Volkswagen AG (OTC: VWAGY). This collaboration primarily focuses on the development of software and electric architecture. However, the partnership does not extend to battery technologies or autonomous driving capabilities. Volkswagen will make an initial investment of $1 billion, with plans for an additional $4 billion investment. Rivian is optimistic about finalizing this joint venture by the end of the current quarter.

Federal Loan Application to Boost Factory Construction

In a bid to expand, Rivian has submitted an application for a federal loan intended to fund the construction of a new EV factory in Georgia. This move has been confirmed through a filing with the U.S. Department of Energy. However, details regarding the loan amount and terms remain undisclosed as the department has yet to make a final decision.

The new factory is projected to initiate partial operations by the third quarter of 2027, with full-scale operations expected to commence by 2028. Rivian had initially paused the construction of this $5 billion facility to prioritize the production of its R2 midsize platform, which is expected to compete against models like Tesla's Model Y. The launch of R2 production is slated for 2026, following a strategic shift to their Illinois facility to save $2.25 billion and ramp up production.

Incentives and Expansion Efforts

Rivian has successfully secured $827 million in incentives from Illinois to support the expansion of its Normal facility, where they also manufacture electric delivery vans for a prominent client. Additionally, the company garnered $1.5 billion in state and local incentives for the upcoming Georgia plant to further enhance their production capabilities.

Current Stock Position and Competitor Insights

As of now, RIVN holds a Zacks Rank #3, indicating a 'Hold' rating. Meanwhile, Rivian is not alone in the competitive landscape of the automotive sector. Other notable companies include Blue Bird Corporation (NASDAQ: BLBD) and BYD Company Limited (OTC: BYDDY), both of which have achieved a Zacks Rank #1, signaling a 'Strong Buy'.

The Zacks Consensus Estimate for BLBD suggests impressive year-over-year growth of 17.58% in sales and a remarkable 215.89% growth in earnings for 2024. Additionally, EPS estimates for BLBD for 2024 and 2025 have seen a significant rise recently. In a similar vein, BYDDY's estimates reflect an expected 21.88% sales growth alongside a 17.12% increase in earnings, emphasizing the growing potential within the electric vehicle sector.

Frequently Asked Questions

What caused Rivian's share price to decline?

Rivian's share price fell after the company announced a reduction in its 2024 production guidance and disappointing third-quarter production and delivery results.

How many vehicles did Rivian produce in the recent quarter?

Rivian produced 13,157 vehicles, which is a decrease from the 16,304 vehicles produced in the same quarter of the previous year.

What is the estimated production for Rivian in 2024?

Rivian now projects its annual vehicle production between 47,000 and 49,000 units, a significant drop from the prior estimate of 57,000 units.

What strategic partnerships has Rivian formed?

Rivian formed a $5 billion joint venture with Volkswagen AG focused on software and electrical architecture, excluding battery technology.

What financial incentives has Rivian secured?

Rivian has received $827 million in incentives from the State of Illinois and $1.5 billion for its Georgia plant expansion.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Explosive Growth: Wellness Economy Now A $7.5T Force

Updated Category News Views 56

A Surge in Global Wellness How about this for a shakeup? The global wellness economy isn't just surviving; it's roaring. Clocking in at a staggering $7.5 trillion in 2025, it's set on a straight trajectory to $10.9 trillion by 2030. Talk about making waves! This isn't just some passing fad; it's where money's being funneled fast, and for good reason. Why the Boom? Ever...

Continue Reading
Fed Signals Rate Hike as Trading Volumes Surge

Updated Category News Views 45

Trading Volumes Surge Amid Economic Shifts You'd think October had a few tricks up its sleeve with how it pulled traders into the game. The 10-year Treasury yield moved up to 5.01%, making folks wonder just how long we'll keep dancing around inflation debates. With the S&P 500 dipping nearly 1% and the Nasdaq Composite spiraling down over 1.5%, investors weren't exactly...

Continue Reading
Navigating Car Wreck Chaos for Legal Protection

Updated Category News Views 46

Clarity Amid Chaos: Handling a Crash in Abilene Let me tell you, if your day starts with a car wreck, every second post-crash counts more than you think. Attorney Chaile Allen out of Abilene's laying down the law on how to protect yourself—because that wreck scene ain't just about bent fenders and bruised egos. It's about getting your ducks in a row for any potential...

Continue Reading
2026 Prix Galien Nominations Spotlight Global Healing

Updated Category News Views 62

Beyond the Hype: Innovating for Healthier Tomorrows Kicking off in Stockholm on December 1st, the 2026 Prix Galien Bridges Awards isn't just some schmooze-fest; it's a hard-hitting showcase of where true innovation can propel healthcare. Over at the Karolinska Institutet, the Galien Foundation is drawing powerhouses from across the Nordics+ region and showcasing...

Continue Reading
CVRx Faces Legal Storm: Class Action Threat Looms

Updated Category News Views 37

Cracks in the Foundation: CVRx's Turmoil Let me tell you, it's not every day you see a company drop a bombshell on investors like CVRx did, shaking up the ole portfolio right down to its socks. NASDAQ:CVRX has found itself embroiled in a class action lawsuit courtesy of a knotty mix of legal woes, unplanned revenue slashes, and executive shake-ups. A few short years ago,...

Continue Reading
Baijiu Shines at Melbourne Cup: A Cultural Exchange

Updated Category News Views 20

Baijiu Brews Cultural Ties at Melbourne Cup If you thought the Melbourne Cup was only about horse racing, think again. This year, the carnival wasn’t just a playground for the equestrian elite but also a stage for cultural exchange, and Chinese baijiu had its moment to shine. It’s not just about sipping a strong spirit; it's about bridging cultures and building...

Continue Reading
MoreBetter's Therapy Co-Investment: A Big Bet on Patient Data

Updated Category News Views 62

Diving Into Uncharted Waters with Bold Moves MoreBetter is stepping right into the murky, unpredictable world of longevity, peptide, and psychedelic therapies with a fresh initiative—the RWE Co-Investment Program. This isn't your run-of-the-mill study announcement; it's a gutsy leap into largely unexplored areas of patient-reported outcomes and real-world evidence. A...

Continue Reading
Pre-Sale Prep: Maximize Your Home's Selling Potential

Updated Category News Views 69

Insights for Sellers: The Road to a Smart Sale Alright, here's the deal: you've got a house to sell, and knowing what to fix up beforehand is like playing a high-stakes game of chess. Miss a move, and it could cost you a chunk of change, or worse, a sale. Enter Rosa Stong, the real estate guru from Becker Stong Real Estate Group, dropping knowledge bombs in a HelloNation...

Continue Reading
Curaleaf Secures Key Approvals in Aurora Acquisition Bid

Updated Category News Views 119

Curaleaf Gets a Green Light for Acquisition Talk about maneuvering a minefield, eh? Curaleaf Holdings just stamped out the last of its paperwork in the cutthroat cannabis industry to acquire Aurora Cannabis. We're looking at the final sign-offs from not one, but two major players: Germany and Canada's competition authorities. That's no small feat when you're trying to...

Continue Reading
Ampa One Partners with Wave Neuroscience for PTSD

Updated Category News Views 106

Ampa and Wave Neuroscience Join Forces In a fresh twist on the neurotechnology scene, Ampa's portable TMS system is teaming up with Wave Neuroscience's MeRT to target PTSD. Science and partnership—combined like a decent scotch and a well-done steak, if you ask me. They've got the FDA clearance on their side, and they're bringing it to the clinics without demanding those...

Continue Reading
angout.com/blog/news?page=2">More News Articles